We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current RAPT market cap is 267.94M. The company's latest EPS is USD -3.3565 and P/E is -2.29.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -21.68M | -24.43M | -31.56M | -28.36M | -33.92M |
| Net Income | -21.24M | -22.95M | -29.27M | -25.28M | -31.37M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 5.04M | 3.81M | 1.53M | 0 |
| Operating Income | -43.63M | -53.21M | -69.21M | -85.8M | -127.06M |
| Net Income | -43M | -52.89M | -69.2M | -83.84M | -116.8M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 209.49M | 266.21M | 248.33M | 220.76M | 199.72M |
| Total Liabilities | 20.18M | 21.04M | 27.86M | 21.08M | 26.92M |
| Total Equity | 189.31M | 245.17M | 220.47M | 199.68M | 172.8M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 84.6M | 118.97M | 198.64M | 266.21M | 173.33M |
| Total Liabilities | 11.48M | 14.79M | 12.26M | 21.04M | 26.29M |
| Total Equity | 73.12M | 104.18M | 186.38M | 245.17M | 147.04M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -47.92M | -70.77M | -18.6M | -47.41M | -69.29M |
| Investing | -4.22M | -45.49M | 25.31M | 57.75M | 83.49M |
| Financing | 55.82M | 131.18M | 116k | 883k | 989k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -35.47M | -40.49M | -61.03M | -70.77M | -97.05M |
| Investing | -843k | -87.44M | -81.35M | -45.49M | 104.13M |
| Financing | 49.9M | 75.46M | 141.48M | 131.18M | 1.45M |
| Market Cap | 267.94M |
| Price to Earnings Ratio | -2.29 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 5.64 |
| Price to Book Ratio | 1.82 |
| Dividend Yield | - |
| Shares Outstanding | 34.8M |
| Average Volume (1 week) | 580.27k |
| Average Volume (1 Month) | 792.54k |
| 52 Week Change | -57.60% |
| 52 Week High | 27.35 |
| 52 Week Low | 6.86 |
| Spread (Intraday) | 0.23 (2.88%) |
| Company Name | RAPT Therapeutics Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://www.rapt.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
